The effect of drug loading and multiple administration on the protein corona formation and brain delivery property of PEG-PLA nanoparticles

被引:21
作者
Tang, Yuyun [1 ]
Gao, Jinchao [1 ]
Wang, Tao [2 ]
Zhang, Qian [1 ]
Wang, Antian [1 ]
Huang, Meng [1 ]
Yu, Renhe [1 ]
Chen, Hongzhuan [1 ,3 ]
Gao, Xiaoling [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Univ, Collaborat Innovat Ctr Translat Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Alzheimers Dis & Related Disorder Ctr, Sch Med, Shanghai Mental Hlth Ctr,Dept Geriatr Psychiat, Shanghai 200025, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Inst Interdisciplinary Integrat Biomed Res, Shanghai 201210, Peoples R China
基金
中国国家自然科学基金;
关键词
Protein corona; Nanoparticles; Brain delivery; Microglia; PEG-PLA; ACCELERATED BLOOD CLEARANCE; COMPLEMENT ACTIVATION PATHWAYS; BIOLOGICAL IDENTITY; PEGYLATED NANOPARTICLES; BIOMOLECULAR CORONA; ADSORPTION; STEALTH; SURFACE; BIODISTRIBUTION; ASSOCIATION;
D O I
10.1016/j.apsb.2021.09.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The presence of protein corona on the surface of nanoparticles modulates their physiological interactions such as cellular association and targeting property. It has been shown that alpha-mangostin (alpha M)-loaded poly(ethylene glycol)-poly(L-lactide) (PEG-PLA) nanoparticles (NP-alpha M) specifically increased low density lipoprotein receptor (LDLR) expression in microglia and improved clearance of amyloid beta (A beta) after multiple administration. However, how do the nanoparticles cross the blood-brain barrier and access microglia remain unknown. Here, we studied the brain delivery property of PEG-PLA nanoparti-cles under different conditions, finding that the nanoparticles exhibited higher brain transport efficiency and microglia uptake efficiency after alpha M loading and multiple administration. To reveal the mechanism, we performed proteomic analysis to characterize the composition of protein corona formed under various conditions, finding that both drug loading and multiple dosing affect the composition of protein corona and subsequently influence the cellular uptake of nanoparticles in b.End3 and BV-2 cells. Complement proteins, immunoglobulins, RAB5A and CD36 were found to be enriched in the corona and associated with the process of nanoparticles uptake. Collectively, we bring a mechanistic understanding about the modulator role of protein corona on targeted drug delivery, and provide theoretical basis for engineering brain or microglia-specific targeted delivery system. (C) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
引用
收藏
页码:2043 / 2056
页数:14
相关论文
共 64 条
[31]   Complement system part I - molecular mechanisms of activation and regulation [J].
Merle, Nicolas S. ;
Church, Sarah Elizabeth ;
Fremeaux-Bacchi, Veronique ;
Roumenina, Lubka T. .
FRONTIERS IN IMMUNOLOGY, 2015, 6
[32]   The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum [J].
Mirshafiee, Vahid ;
Kim, Raehyun ;
Mahmoudi, Morteza ;
Kraft, Mary L. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2016, 75 :188-195
[33]   Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective [J].
Moghimi, S. M. ;
Hunter, A. C. ;
Andresen, T. L. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52, 2012, 52 :481-503
[34]  
Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]
[35]  
Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
[36]  
Olivier Jean-Christophe, 2005, NeuroRx, V2, P108, DOI 10.1007/BF03206647
[37]   PEGylated nanoparticles for biological and pharmaceutical applications [J].
Otsuka, H ;
Nagasaki, Y ;
Kataoka, K .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (03) :403-419
[38]   Effects of Microparticle Size and Fc Density on Macrophage Phagocytosis [J].
Pacheco, Patricia ;
White, David ;
Sulchek, Todd .
PLOS ONE, 2013, 8 (04)
[39]   Drug transport across the blood-brain barrier [J].
Pardridge, William M. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (11) :1959-1972
[40]   Protein corona and nanoparticles: how can we investigate on? [J].
Pederzoli, Francesca ;
Tosi, Giovanni ;
Vandelli, Maria Angela ;
Belletti, Daniela ;
Forni, Flavio ;
Ruozi, Barbara .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2017, 9 (06)